<?xml version="1.0" encoding="UTF-8"?>
<p id="para0015">Immunisation of BALB/c mice was conducted either at Advinus Therapeutics Limited, Bangalore, India (IAEC No. 008/Feb 2016) or the International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi (ICGEB/IAEC/08/2016/RGP-14 and ICGEB/IAEC/02042019/RGP-2). DENV type 2 (DENV-2) challenge experiments using AG129 mice were carried out at ICGEB, New Delhi, India (ICGEB/IAEC/2017/01/RGP-16). BALB/c and AG129 mouse experiments were strictly compliant with the guidelines of the Committee for the Purpose of Control and Supervision of Experiments on Animals of the Government of India. Experiments with C57BL/6 
 <italic>Stat2</italic>
 <sup>−/−</sup> mice were performed at Icahn School of Medicine at Mount Sinai (IACUC Approved Protocol #s 13-0193 and LA11-00147) in accordance with the US federal regulations and the guidelines contained in the National Research Council Guide for the Care and Use of Laboratory Animals.
</p>
